Global Receptor Tyrosine Protein Kinase ERBB3 Market Outlook (2026–2036)
Market Overview
Receptor Tyrosine Protein Kinase ERBB3 (HER3) is a member of the ERBB family that plays a critical role in tumor progression, drug resistance, and oncogenic signaling pathways, particularly in solid tumors. Although ERBB3 has limited intrinsic kinase activity, its ability to heterodimerize with other ERBB receptors makes it a high-value therapeutic target in oncology drug development.
The global Receptor Tyrosine Protein Kinase ERBB3 market was valued at USD XX million in 2020 and is projected to reach USD XX million by 2036, expanding at a CAGR of XX% during 2026–2036. Market growth is driven by rising cancer prevalence, increased R&D investments in targeted biologics, and growing interest in combination oncology therapies.
Key Market Players
Major Pharmaceutical & Biotechnology Companies
-
AstraZeneca
-
AVEO Pharmaceuticals
-
F. Hoffmann-La Roche
-
GlaxoSmithKline
-
Novartis
-
Hanmi Pharmaceutical
-
ImmunoGen
-
Merus
-
Sorrento Therapeutics
-
Symphogen
-
Shanghai Fosun Pharmaceutical
Additional & Emerging Players (Expanded Coverage)
-
Etubics Corporation
-
GamaMabs Pharma
-
Kolltan Pharmaceuticals
-
Merrimack Pharmaceuticals
-
Sihuan Pharmaceutical
-
Takis
Segments Analysis
By Product Type
-
BA-0702
-
CDX-3379
-
Elgemtumab
-
ETBX-031
-
Others (early-stage and pipeline molecules)
By Drug Class (Expanded Segment)
-
Monoclonal antibodies
-
Bispecific antibodies
-
Antibody-drug conjugates (ADCs)
-
Combination therapy agents
By Application
-
Non-Small Cell Lung Carcinoma (NSCLC)
-
Solid Tumors
-
Melanoma
-
Colorectal Cancer
-
Others
-
Breast cancer
-
Head & neck squamous cell carcinoma
-
Gastric cancer
-
By Development Stage (Additional Segment)
-
Preclinical
-
Phase I
-
Phase II
-
Phase III
-
Approved / Late-stage
By End User (Additional Segment)
-
Hospitals & oncology centers
-
Research institutes
-
Contract research organizations (CROs)
Regional Analysis
North America
-
Dominant market due to strong oncology R&D ecosystem
-
High concentration of biotech firms and clinical trials
-
Favorable regulatory pathways for breakthrough therapies
Europe
-
Strong presence of global pharmaceutical leaders
-
Growth supported by public-private oncology research collaborations
Asia-Pacific
-
Fastest-growing region
-
Rising cancer burden in China, India, and Japan
-
Increasing investment in biologics manufacturing
Central & South America
-
Gradual growth driven by improving cancer diagnostics and treatment access
Middle East & Africa
-
Early-stage market
-
Growth potential linked to expanding oncology infrastructure
Porter’s Five Forces Analysis
-
Threat of New Entrants – Low
-
High R&D cost, regulatory complexity, and patent barriers
-
-
Bargaining Power of Suppliers – Moderate
-
Specialized biologics manufacturing limits supplier pool
-
-
Bargaining Power of Buyers – Moderate
-
Large hospitals and governments exert pricing pressure
-
-
Threat of Substitutes – Moderate
-
Other targeted therapies and immuno-oncology drugs
-
-
Competitive Rivalry – High
-
Intense competition in oncology pipelines and clinical outcomes
-
SWOT Analysis
Strengths
-
High unmet medical need in oncology
-
Strong clinical rationale for ERBB3 targeting
Weaknesses
-
Complex biology and signaling redundancy
-
High clinical trial failure rates
Opportunities
-
Combination therapies with EGFR and HER2 inhibitors
-
Expansion into resistant tumor populations
-
Personalized and biomarker-driven treatments
Threats
-
Regulatory delays
-
Competition from next-generation immunotherapies
Trend Analysis
-
Rising focus on HER3 as a resistance mechanism
-
Growth in bispecific antibodies and ADC platforms
-
Increasing use of precision oncology and companion diagnostics
-
Strategic licensing and co-development agreements
Market Drivers
-
Increasing global cancer incidence
-
Demand for targeted and less toxic therapies
-
Advances in antibody engineering technologies
Market Challenges
-
Long development timelines
-
High R&D and manufacturing costs
-
Clinical efficacy variability across tumor types
Value Chain Analysis
-
Target discovery & validation
-
Antibody engineering
-
Preclinical development
-
Clinical trials (Phase I–III)
-
Regulatory approval
-
Commercial manufacturing
-
Distribution to oncology centers
Quick Recommendations for Stakeholders
-
Pharmaceutical Companies: Invest in combination and biomarker-guided ERBB3 therapies
-
Biotech Firms: Focus on bispecific and ADC-based platforms
-
Investors: Target late-stage pipeline assets and Asia-Pacific expansion
-
Healthcare Providers: Prepare for integration of personalized ERBB3-targeted treatments
Study Timeline
-
Historical Period: 2020–2024
-
Base Year: 2025
-
Estimated Year: 2026
-
Forecast Period: 2026–2036
Table of Contents
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2026
1 Industry Overview of Receptor Tyrosine Protein Kinase ERBB 3
1.1 Definition and Specifications of Receptor Tyrosine Protein Kinase ERBB 3
1.1.1 Definition of Receptor Tyrosine Protein Kinase ERBB 3
1.1.2 Specifications of Receptor Tyrosine Protein Kinase ERBB 3
1.2 Classification of Receptor Tyrosine Protein Kinase ERBB 3
1.2.1 BA-0702
1.2.2 CDX-3379
1.2.3 Elgemtumab
1.2.4 ETBX-031
1.2.5 Others
1.3 Applications of Receptor Tyrosine Protein Kinase ERBB 3
1.3.1 Non-Small Cell Carcinoma
1.3.2 Solid Tumor
1.3.3 Melanoma
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3
2.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
2.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 3
3 Technical Data and Manufacturing Plants Analysis of Receptor Tyrosine Protein Kinase ERBB 3
3.1 Capacity and Commercial Production Date of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
3.3 R&D Status and Technology Source of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
4 Global Receptor Tyrosine Protein Kinase ERBB 3 Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Receptor Tyrosine Protein Kinase ERBB 3 Capacity and Growth Rate Analysis
4.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate Analysis
4.3.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Price
4.4.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis (Company Segment)
5 Receptor Tyrosine Protein Kinase ERBB 3 Regional Market Analysis
5.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.1.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.1.2 North America E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.1.4 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
5.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.2.1 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.2.2 Europe E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.2.4 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
5.3 China Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.3.1 China Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.3.2 China E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.3.4 China Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
5.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.4.1 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.4.2 Japan E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.4.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
5.5 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.5.1 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.5.2 Southeast Asia E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.5.4 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
5.6 India Receptor Tyrosine Protein Kinase ERBB 3 Market Analysis
5.6.1 India Receptor Tyrosine Protein Kinase ERBB 3 Market Overview
5.6.2 India E Receptor Tyrosine Protein Kinase ERBB 3 Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Analysis
5.6.4 India Receptor Tyrosine Protein Kinase ERBB 3 Market Share Analysis
6 Global E Receptor Tyrosine Protein Kinase ERBB 3 Segment Market Analysis (by Type)
6.1 Global E Receptor Tyrosine Protein Kinase ERBB 3 Sales by Type
6.2 Different Types of Receptor Tyrosine Protein Kinase ERBB 3 Product Interview Price Analysis
6.3 Different Types of Receptor Tyrosine Protein Kinase ERBB 3 Product Driving Factors Analysis
6.3.1 BA-0702 Growth Driving Factor Analysis
6.3.2 CDX-3379 Growth Driving Factor Analysis
6.3.3 Elgemtumab Growth Driving Factor Analysis
6.3.4 ETBX-031 Growth Driving Factor Analysis
6.3.5 Others Growth Driving Factor Analysis
7 Global E Receptor Tyrosine Protein Kinase ERBB 3 Segment Market Analysis (by Application)
7.1 Global E Receptor Tyrosine Protein Kinase ERBB 3 Consumption by Application
7.2 Different Application of Receptor Tyrosine Protein Kinase ERBB 3 Product Interview Price Analysis
7.3 Different Application of Receptor Tyrosine Protein Kinase ERBB 3 Product Driving Factors Analysis
7.3.1 Non-Small Cell Carcinoma of Receptor Tyrosine Protein Kinase ERBB 3 Growth Driving Factor Analysis
7.3.2 Solid Tumor of Receptor Tyrosine Protein Kinase ERBB 3 Growth Driving Factor Analysis
7.3.3 Melanoma of Receptor Tyrosine Protein Kinase ERBB 3 Growth Driving Factor Analysis
7.3.4 Colorectal Cancer of Receptor Tyrosine Protein Kinase ERBB 3 Growth Driving Factor Analysis
7.3.5 Others of Receptor Tyrosine Protein Kinase ERBB 3 Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Receptor Tyrosine Protein Kinase ERBB 3
8.1 AstraZeneca Plc
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.2 AVEO Pharmaceuticals, Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.3 Etubics Corporation
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.5 GamaMabs Pharma S.A.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.6 GlaxoSmithKline Plc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.7 Hanmi Pharmaceuticals, Co. Ltd.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.8 ImmunoGen, Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.9 Kolltan Pharmaceuticals, Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.10 Merrimack Pharmaceuticals, Inc.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution Analysis
8.11 Merus B.V.
8.12 Novartis AG
8.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
8.14 Sihuan Pharmaceutical Holdings Group Ltd.
8.15 Sorrento Therapeutics, Inc.
8.16 Symphogen A/S
8.17 Takis S.r.l.
9 Development Trend of Analysis of Receptor Tyrosine Protein Kinase ERBB 3 Market
9.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Trend Analysis
9.1.1 Global 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Sales Price Forecast
9.2 Receptor Tyrosine Protein Kinase ERBB 3 Regional Market Trend
9.2.1 North America 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.2.2 Europe 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.2.3 China 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.2.4 Japan 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.2.6 India 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Forecast
9.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Trend (Product Type)
9.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Trend (Application)
10 Receptor Tyrosine Protein Kinase ERBB 3 Marketing Type Analysis
10.1 Receptor Tyrosine Protein Kinase ERBB 3 Regional Marketing Type Analysis
10.2 Receptor Tyrosine Protein Kinase ERBB 3 International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Receptor Tyrosine Protein Kinase ERBB 3 by Region
10.4 Receptor Tyrosine Protein Kinase ERBB 3 Supply Chain Analysis
11 Consumers Analysis of Receptor Tyrosine Protein Kinase ERBB 3
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Receptor Tyrosine Protein Kinase ERBB 3 Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Receptor Tyrosine Protein Kinase ERBB 3
Table Product Specifications of Receptor Tyrosine Protein Kinase ERBB 3
Table Classification of Receptor Tyrosine Protein Kinase ERBB 3
Figure Global Production Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Type in
Figure BA-0702 Picture
Table Major Manufacturers of BA-0702
Figure CDX-3379 Picture
Table Major Manufacturers of CDX-3379
Figure Elgemtumab Picture
Table Major Manufacturers of Elgemtumab
Figure ETBX-031 Picture
Table Major Manufacturers of ETBX-031
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Receptor Tyrosine Protein Kinase ERBB 3
Figure Global Consumption Volume Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Application in
Figure Non-Small Cell Carcinoma Examples
Table Major Consumers in Non-Small Cell Carcinoma
Figure Solid Tumor Examples
Table Major Consumers in Solid Tumor
Figure Melanoma Examples
Table Major Consumers in Melanoma
Figure Colorectal Cancer Examples
Table Major Consumers in Colorectal Cancer
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Regions
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Figure Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Figure India Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) (2013-2025)
Table Receptor Tyrosine Protein Kinase ERBB 3 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase ERBB 3 in
Figure Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase ERBB 3
Figure Industry Chain Structure of Receptor Tyrosine Protein Kinase ERBB 3
Table Capacity and Commercial Production Date of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
Table Manufacturing Plants Distribution of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
Table R&D Status and Technology Source of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
Table Raw Materials Sources Analysis of Global Receptor Tyrosine Protein Kinase ERBB 3 Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure Global E Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Volume) and Growth Rate
Figure Global E Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Value) and Growth Rate
Table E Global Receptor Tyrosine Protein Kinase ERBB 3 Capacity and Growth Rate
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Capacity (K Pcs) List (Company Segment)
Table E Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) and Growth Rate
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) List (Company Segment)
Table E Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure North America E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure Europe E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure China E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure Japan E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure Southeast Asia E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 E
Figure India E Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs)
Figure India Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share
Table Global E Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Type
Table Different Types Receptor Tyrosine Protein Kinase ERBB 3 Product Interview Price
Table Global E Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Pcs) by Application
Table Different Application Receptor Tyrosine Protein Kinase ERBB 3 Product Interview Price
Table AstraZeneca Plc Information List
Table Product Overview
Table AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table AVEO Pharmaceuticals, Inc. Information List
Table Product Overview
Table AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table Etubics Corporation Information List
Table Product Overview
Table Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table F. Hoffmann-La Roche Ltd. Information List
Table Product Overview
Table F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table GamaMabs Pharma S.A. Information List
Table Product Overview
Table GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table GlaxoSmithKline Plc Information List
Table Product Overview
Table GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table Hanmi Pharmaceuticals, Co. Ltd. Information List
Table Product Overview
Table Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table ImmunoGen, Inc. Information List
Table Product Overview
Table ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table Kolltan Pharmaceuticals, Inc. Information List
Table Product Overview
Table Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table Merrimack Pharmaceuticals, Inc. Information List
Table Product Overview
Table Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Business Region Distribution
Table Merus B.V. Information List
Table Novartis AG Information List
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Information List
Table Sihuan Pharmaceutical Holdings Group Ltd. Information List
Table Sorrento Therapeutics, Inc. Information List
Table Symphogen A/S Information List
Table Takis S.r.l. Information List
Figure Global 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Receptor Tyrosine Protein Kinase ERBB 3 Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Receptor Tyrosine Protein Kinase ERBB 3 by Application 2018-2025
Table Traders or Distributors with Contact Information of Receptor Tyrosine Protein Kinase ERBB 3 by Region
Key Market Players
Major Pharmaceutical & Biotechnology Companies
-
AstraZeneca
-
AVEO Pharmaceuticals
-
F. Hoffmann-La Roche
-
GlaxoSmithKline
-
Novartis
-
Hanmi Pharmaceutical
-
ImmunoGen
-
Merus
-
Sorrento Therapeutics
-
Symphogen
-
Shanghai Fosun Pharmaceutical
Additional & Emerging Players (Expanded Coverage)
-
Etubics Corporation
-
GamaMabs Pharma
-
Kolltan Pharmaceuticals
-
Merrimack Pharmaceuticals
-
Sihuan Pharmaceutical
-
Takis
Segments Analysis
By Product Type
-
BA-0702
-
CDX-3379
-
Elgemtumab
-
ETBX-031
-
Others (early-stage and pipeline molecules)
By Drug Class (Expanded Segment)
-
Monoclonal antibodies
-
Bispecific antibodies
-
Antibody-drug conjugates (ADCs)
-
Combination therapy agents
By Application
-
Non-Small Cell Lung Carcinoma (NSCLC)
-
Solid Tumors
-
Melanoma
-
Colorectal Cancer
-
Others
-
Breast cancer
-
Head & neck squamous cell carcinoma
-
Gastric cancer
-
By Development Stage (Additional Segment)
-
Preclinical
-
Phase I
-
Phase II
-
Phase III
-
Approved / Late-stage
By End User (Additional Segment)
-
Hospitals & oncology centers
-
Research institutes
-
Contract research organizations (CROs)